Annual CAPEX
$2.17 M
+$817.00 K+60.47%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual capital expenditures is currently $2.17 million, with the most recent change of +$817.00 thousand (+60.47%) on 31 December 2023. During the last 3 years, it has risen by +$1.65 million (+321.79%). BCRX annual CAPEX is now -58.92% below its all-time high of $5.28 million, reached on 31 December 2016.BCRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$59.00 K
-$96.00 K-61.94%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly capital expenditures is currently $59.00 thousand, with the most recent change of -$96.00 thousand (-61.94%) on 30 September 2024. Over the past year, it has dropped by -$928.00 thousand (-94.02%). BCRX quarterly CAPEX is now -98.54% below its all-time high of $4.05 million, reached on 31 December 2015.BCRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.00 M
-$928.00 K-48.06%
30 September 2024
Summary:
BioCryst Pharmaceuticals TTM capital expenditures is currently $1.00 million, with the most recent change of -$928.00 thousand (-48.06%) on 30 September 2024. Over the past year, it has dropped by -$1.14 million (-53.13%). BCRX TTM CAPEX is now -89.24% below its all-time high of $9.32 million, reached on 30 September 2016.BCRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.5% | -94.0% | -53.1% |
| 3 y3 years | +321.8% | -83.8% | -30.0% |
| 5 y5 years | +492.4% | -28.9% | +173.3% |
BCRX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.1% | +321.8% | -94.7% | at low | -62.7% | at low |
| 5 y | 5 years | -9.1% | +532.1% | -94.7% | at low | -62.7% | +192.4% |
| alltime | all time | -58.9% | +7126.7% | -98.5% | +146.0% | -89.2% | +9018.2% |
BioCryst Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $59.00 K(-61.9%) | $1.00 M(-48.1%) |
| June 2024 | - | $155.00 K(-34.0%) | $1.93 M(-13.9%) |
| Mar 2024 | - | $235.00 K(-57.6%) | $2.24 M(+3.5%) |
| Dec 2023 | $2.17 M(+60.5%) | $554.00 K(-43.9%) | $2.17 M(+1.3%) |
| Sept 2023 | - | $987.00 K(+111.3%) | $2.14 M(+61.1%) |
| June 2023 | - | $467.00 K(+191.9%) | $1.33 M(+20.2%) |
| Mar 2023 | - | $160.00 K(-69.6%) | $1.10 M(-18.2%) |
| Dec 2022 | $1.35 M(-43.4%) | $526.00 K(+200.6%) | $1.35 M(-30.1%) |
| Sept 2022 | - | $175.00 K(-28.3%) | $1.93 M(-8.9%) |
| June 2022 | - | $244.00 K(-39.9%) | $2.12 M(-21.1%) |
| Mar 2022 | - | $406.00 K(-63.4%) | $2.69 M(+12.9%) |
| Dec 2021 | $2.38 M(+364.0%) | $1.11 M(+203.6%) | $2.38 M(+66.6%) |
| Sept 2021 | - | $365.00 K(-55.1%) | $1.43 M(+15.6%) |
| June 2021 | - | $813.00 K(+721.2%) | $1.24 M(+149.3%) |
| Mar 2021 | - | $99.00 K(-36.1%) | $497.00 K(-3.3%) |
| Dec 2020 | $514.00 K(+49.9%) | $155.00 K(-9.9%) | $514.00 K(+17.1%) |
| Sept 2020 | - | $172.00 K(+142.3%) | $439.00 K(+25.4%) |
| June 2020 | - | $71.00 K(-38.8%) | $350.00 K(-4.4%) |
| Mar 2020 | - | $116.00 K(+45.0%) | $366.00 K(+6.7%) |
| Dec 2019 | $343.00 K(-6.3%) | $80.00 K(-3.6%) | $343.00 K(-6.5%) |
| Sept 2019 | - | $83.00 K(-4.6%) | $367.00 K(+12.9%) |
| June 2019 | - | $87.00 K(-6.5%) | $325.00 K(-23.3%) |
| Mar 2019 | - | $93.00 K(-10.6%) | $424.00 K(+15.8%) |
| Dec 2018 | $366.00 K(+11.6%) | $104.00 K(+153.7%) | $366.00 K(-2.9%) |
| Sept 2018 | - | $41.00 K(-78.0%) | $377.00 K(-28.2%) |
| June 2018 | - | $186.00 K(+431.4%) | $525.00 K(+45.8%) |
| Mar 2018 | - | $35.00 K(-69.6%) | $360.00 K(+9.8%) |
| Dec 2017 | $328.00 K(-93.8%) | $115.00 K(-39.2%) | $328.00 K(+54.7%) |
| Sept 2017 | - | $189.00 K(+800.0%) | $212.00 K(+5.0%) |
| June 2017 | - | $21.00 K(+600.0%) | $202.00 K(-90.0%) |
| Mar 2017 | - | $3000.00(-400.0%) | $2.02 M(-61.7%) |
| Dec 2016 | $5.28 M(+3.0%) | -$1000.00(-100.6%) | $5.28 M(-43.4%) |
| Sept 2016 | - | $179.00 K(-90.3%) | $9.32 M(+0.4%) |
| June 2016 | - | $1.84 M(-43.6%) | $9.29 M(+18.8%) |
| Mar 2016 | - | $3.26 M(-19.4%) | $7.82 M(+52.6%) |
| Dec 2015 | $5.12 M(+4732.1%) | $4.05 M(+2749.3%) | $5.12 M(+348.9%) |
| Sept 2015 | - | $142.00 K(-61.5%) | $1.14 M(+10.5%) |
| June 2015 | - | $369.00 K(-34.7%) | $1.03 M(+55.6%) |
| Mar 2015 | - | $565.00 K(+769.2%) | $664.00 K(+526.4%) |
| Dec 2014 | $106.00 K(+253.3%) | $65.00 K(+91.2%) | $106.00 K(+135.6%) |
| Sept 2014 | - | $34.00 K(>+9900.0%) | $45.00 K(+309.1%) |
| June 2014 | - | $0.00(-100.0%) | $11.00 K(-70.3%) |
| Mar 2014 | - | $7000.00(+75.0%) | $37.00 K(+23.3%) |
| Dec 2013 | $30.00 K(-73.5%) | $4000.00(>+9900.0%) | $30.00 K(+25.0%) |
| Sept 2013 | - | $0.00(-100.0%) | $24.00 K(-20.0%) |
| June 2013 | - | $26.00 K(-1400.0%) | $30.00 K(-73.5%) |
| Dec 2012 | $113.00 K(+105.5%) | -$2000.00(-133.3%) | $113.00 K(-2.6%) |
| Sept 2012 | - | $6000.00(-85.0%) | $116.00 K(+4.5%) |
| June 2012 | - | $40.00 K(-42.0%) | $111.00 K(+18.1%) |
| Mar 2012 | - | $69.00 K(+6800.0%) | $94.00 K(+70.9%) |
| Dec 2011 | $55.00 K(-83.1%) | $1000.00(0.0%) | $55.00 K(-17.9%) |
| Sept 2011 | - | $1000.00(-95.7%) | $67.00 K(-48.9%) |
| June 2011 | - | $23.00 K(-23.3%) | $131.00 K(-51.8%) |
| Mar 2011 | - | $30.00 K(+130.8%) | $272.00 K(-16.3%) |
| Dec 2010 | $325.00 K(-46.2%) | $13.00 K(-80.0%) | $325.00 K(-19.7%) |
| Sept 2010 | - | $65.00 K(-60.4%) | $404.70 K(-15.6%) |
| June 2010 | - | $164.00 K(+97.6%) | $479.70 K(-18.9%) |
| Mar 2010 | - | $83.00 K(-10.5%) | $591.70 K(-2.0%) |
| Dec 2009 | $603.70 K | $92.70 K(-33.8%) | $603.70 K(+3.5%) |
| Sept 2009 | - | $140.00 K(-49.3%) | $583.30 K(-34.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $276.00 K(+190.5%) | $889.30 K(-22.2%) |
| Mar 2009 | - | $95.00 K(+31.4%) | $1.14 M(-5.7%) |
| Dec 2008 | $1.21 M(-63.7%) | $72.30 K(-83.8%) | $1.21 M(-54.0%) |
| Sept 2008 | - | $446.00 K(-15.8%) | $2.63 M(-22.5%) |
| June 2008 | - | $530.00 K(+223.2%) | $3.40 M(+5.2%) |
| Mar 2008 | - | $164.00 K(-89.0%) | $3.23 M(-3.4%) |
| Dec 2007 | $3.34 M(+117.9%) | $1.49 M(+23.4%) | $3.34 M(+36.6%) |
| Sept 2007 | - | $1.21 M(+234.5%) | $2.45 M(+71.7%) |
| June 2007 | - | $362.00 K(+30.7%) | $1.43 M(+16.9%) |
| Mar 2007 | - | $277.00 K(-53.7%) | $1.22 M(-20.5%) |
| Dec 2006 | $1.53 M(+2921.1%) | $597.70 K(+216.2%) | $1.53 M(+89.8%) |
| Sept 2006 | - | $189.00 K(+21.2%) | $808.80 K(+12.2%) |
| June 2006 | - | $156.00 K(-73.6%) | $720.80 K(+19.8%) |
| Mar 2006 | - | $592.00 K(-561.8%) | $601.80 K(+1084.6%) |
| Dec 2005 | $50.80 K(-81.6%) | -$128.20 K(-226.9%) | $50.80 K(-82.4%) |
| Sept 2005 | - | $101.00 K(+173.0%) | $288.90 K(+36.3%) |
| June 2005 | - | $37.00 K(-9.8%) | $211.90 K(+9.3%) |
| Mar 2005 | - | $41.00 K(-62.7%) | $193.90 K(-29.7%) |
| Dec 2004 | $275.90 K(+433.7%) | $109.90 K(+357.9%) | $275.90 K(+49.4%) |
| Sept 2004 | - | $24.00 K(+26.3%) | $184.70 K(+10.8%) |
| June 2004 | - | $19.00 K(-84.6%) | $166.70 K(+9.9%) |
| Mar 2004 | - | $123.00 K(+557.8%) | $151.70 K(+193.4%) |
| Dec 2003 | $51.70 K(-87.3%) | $18.70 K(+211.7%) | $51.70 K(+57.1%) |
| Sept 2003 | - | $6000.00(+50.0%) | $32.90 K(+27.0%) |
| June 2003 | - | $4000.00(-82.6%) | $25.90 K(-86.4%) |
| Mar 2003 | - | $23.00 K(<-9900.0%) | $190.90 K(-53.2%) |
| Dec 2002 | $407.90 K(-84.3%) | -$100.00(-90.0%) | $407.90 K(-65.5%) |
| Sept 2002 | - | -$1000.00(-100.6%) | $1.18 M(-48.0%) |
| June 2002 | - | $169.00 K(-29.6%) | $2.28 M(+1.9%) |
| Mar 2002 | - | $240.00 K(-69.0%) | $2.23 M(-14.2%) |
| Dec 2001 | $2.60 M(-4.4%) | $775.40 K(-28.9%) | $2.60 M(-11.4%) |
| Sept 2001 | - | $1.09 M(+759.1%) | $2.94 M(+7.7%) |
| June 2001 | - | $127.00 K(-79.2%) | $2.73 M(-11.5%) |
| Mar 2001 | - | $611.00 K(-45.0%) | $3.09 M(+13.3%) |
| Dec 2000 | $2.72 M(+172.3%) | $1.11 M(+26.1%) | $2.72 M(+28.9%) |
| Sept 2000 | - | $881.00 K(+82.8%) | $2.11 M(+58.7%) |
| June 2000 | - | $482.00 K(+93.6%) | $1.33 M(+26.9%) |
| Mar 2000 | - | $249.00 K(-50.2%) | $1.05 M(+4.9%) |
| Dec 1999 | $1.00 M(+150.0%) | $500.00 K(+400.0%) | $1.00 M(+100.0%) |
| Sept 1999 | - | $100.00 K(-50.0%) | $500.00 K(0.0%) |
| June 1999 | - | $200.00 K(0.0%) | $500.00 K(+25.0%) |
| Mar 1999 | - | $200.00 K(>+9900.0%) | $400.00 K(0.0%) |
| Dec 1998 | $400.00 K(-63.6%) | $0.00(-100.0%) | $400.00 K(-20.0%) |
| Sept 1998 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| June 1998 | - | $100.00 K(-50.0%) | $500.00 K(-50.0%) |
| Mar 1998 | - | $200.00 K(+100.0%) | $1.00 M(-9.1%) |
| Dec 1997 | $1.10 M(+266.7%) | $100.00 K(0.0%) | $1.10 M(0.0%) |
| Sept 1997 | - | $100.00 K(-83.3%) | $1.10 M(0.0%) |
| June 1997 | - | $600.00 K(+100.0%) | $1.10 M(+83.3%) |
| Mar 1997 | - | $300.00 K(+200.0%) | $600.00 K(+100.0%) |
| Dec 1996 | $300.00 K(+50.0%) | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Sept 1996 | - | $100.00 K(0.0%) | $200.00 K(0.0%) |
| June 1996 | - | $100.00 K(>+9900.0%) | $200.00 K(0.0%) |
| Dec 1995 | $200.00 K(-50.0%) | $0.00(-100.0%) | $200.00 K(-33.3%) |
| Sept 1995 | - | $100.00 K(>+9900.0%) | $300.00 K(0.0%) |
| June 1995 | - | $0.00(-100.0%) | $300.00 K(-25.0%) |
| Mar 1995 | - | $100.00 K(0.0%) | $400.00 K(0.0%) |
| Dec 1994 | $400.00 K | $100.00 K(0.0%) | $400.00 K(+33.3%) |
| Sept 1994 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1994 | - | $100.00 K | $100.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual CAPEX year-on-year change?
- What is BioCryst Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly CAPEX year-on-year change?
- What is BioCryst Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM CAPEX year-on-year change?
What is BioCryst Pharmaceuticals annual capital expenditures?
The current annual CAPEX of BCRX is $2.17 M
What is the all time high annual CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual capital expenditures is $5.28 M
What is BioCryst Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, BCRX annual capital expenditures has changed by +$817.00 K (+60.47%)
What is BioCryst Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of BCRX is $59.00 K
What is the all time high quarterly CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly capital expenditures is $4.05 M
What is BioCryst Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, BCRX quarterly capital expenditures has changed by -$928.00 K (-94.02%)
What is BioCryst Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of BCRX is $1.00 M
What is the all time high TTM CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM capital expenditures is $9.32 M
What is BioCryst Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, BCRX TTM capital expenditures has changed by -$1.14 M (-53.13%)